Stonepine Capital Management »

BioAtla shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of BioAtla (BCAB) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in BioAtla

Tip: Access up to 7 years of quarterly data

All positions including BioAtla held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioAtla by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $68k 16k 4.14

More positions owned by Stonepine Capital Management

Evolus (EOLS)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Nektar Therapeutics Com New (NKTR)
Ultragenyx Pharmaceutical (RARE)
Camp4 Therapeutics Corp Com 13469v Ab 4 Camtek Ltd Note 12/0 (CAMP)
Insmed Com Par $.01 Call Option (INSM)
Eloxx Pharmaceuticals Com New
Kazia Therapeutics Sponsored Ads (KZIA)
Medtronic SHS Call Option (MDT)
Indivior Pharmaceuticals (INDV)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Abbott Laboratories Call Option (ABT)
Satellos Bioscience (MSLE)

View all positions for Stonepine Capital Management

Top funds holding BioAtla

Millennium Management
Lido Advisors
Stonepine Capital Management
Acadian Asset Management
Hrt Financial
Geode Capital Management
Deutsche Bank Aktiengesellschaft
BlackRock
Vanguard Capital Management
UBS Group
Vanguard Fiduciary Trust
Tower Research Capital
Forum Finance Group
SBI Securities
Twin Lakes Capital Management

View all funds holding BioAtla